Massive transfusion and severe blood shortages: establishing and implementing predictors of futility.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 34794769.
- Also identified by DOI 10.1016/j.bja.2021.10.013.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Massive transfusion protocols were developed to deliver blood for life-threatening haemorrhage; however, there are no guidelines to advise when massive transfusion protocols may be considered futile. Early recognition of clinical futility remains a challenge as studies have not identified variables that can accurately determine early mortality. As blood is a scarce resource, efforts to distribute it equitably to all patients who would benefit are of paramount importance. In this editorial we discuss recent data and various aspects important in developing and implementing tools that assist with determining futility in massive transfusion.
Medical subject headings
- Blood Transfusion
- Medical Futility